Phase II trial of intravesical gemcitabine in BCG refractory transitional cell carcinoma of the bladder

被引：3
|
作者：
Dalbagni, G
Mazumdar, M
Russo, P
Sheinfeld, J
Donat, SM
Bochner, BH
Herr, HW
Sogani, P
Ginty, J
Bajorin, DF
机构：
来源：
JOURNAL OF UROLOGY | 2004年 / 171卷 / 04期
关键词：
D O I：
10.1016/S0022-5347(18)37536-0
中图分类号：
R5 [内科学]; R69 [泌尿科学（泌尿生殖系疾病）];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：72 / 72
页数：1
相关论文
共 50 条
  • [1] Phase II trial of intravesical gemcitabine in BCG-refractory transitional cell carcinoma of the bladder
    Dalbagni, G
    Russo, P
    Ben-Porat, L
    Donat, SM
    Herr, HW
    Bochner, BH
    Bajorin, DF
    [J]. JOURNAL OF UROLOGY, 2006, 175 (04): : 270 - 271
  • [2] Phase I trial of intravesical gemcitabine in BCG-refractory transitional cell carcinoma of the bladder
    Dalbagni, G
    Russo, P
    Sheinfeld, J
    Mazumdar, M
    Tong, W
    Rabbani, F
    Donat, SM
    Herr, HW
    Sogani, P
    Depalma, D
    Bajorin, D
    [J]. JOURNAL OF UROLOGY, 2002, 167 (04): : 186 - 186
  • [3] Phase II trial of intravesical gemcitabine in bacille Calmette-Guerin-refractory transitional cell carcinoma of the bladder
    Dalbagni, G
    Russo, P
    Bochner, B
    Ben-Porat, L
    Sheinfeld, J
    Sogani, P
    Donat, MS
    Herr, HW
    Bajorin, D
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2006, 24 (18) : 2729 - 2734
  • [4] Intravesical gemcitabine in management of BCG refractory superficial transitional cell carcinoma (TCC) of urinary bladder
    Mohanty, N. K.
    Nayak, R. L.
    Arora, R. P.
    Saxena, S.
    [J]. BJU INTERNATIONAL, 2007, 99 : 14 - 14
  • [5] Phase I trial of intravesical gemcitabine in bacillus Calmette-Guerin-refractory transitional-cell carcinoma of the bladder
    Dalbagni, G
    Russo, P
    Sheinfeld, J
    Mazumdar, M
    Tong, W
    Rabbani, F
    Donat, MS
    Herr, HW
    Sogani, P
    dePalma, D
    Bojorin, D
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2002, 20 (15) : 3193 - 3198
  • [6] Intravesical gemcitabine in BCG-refractory T1G3 transitional cell carcinoma of the bladder: A pilot study
    Gacci, M
    Bartoletti, R
    Cai, T
    Nerozzi, S
    Pinzi, N
    Repetti, F
    Viggiani, F
    Ghezzi, P
    Nesi, G
    Carini, M
    [J]. UROLOGIA INTERNATIONALIS, 2006, 76 (02) : 106 - 111
  • [7] Intravesical gemcitabine therapy for superficial transitional cell carcinoma of the bladder: A phase I and pharmacokinetic study
    Laufer, M
    Ramalingam, S
    Schoenberg, MP
    Haisfield-Wolf, ME
    Zuhowski, EG
    Trueheart, IN
    Eisenberger, MA
    Nativ, O
    Egorin, MJ
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2003, 21 (04) : 697 - 703
  • [8] Management of BCG non-responders with fixed dose intravesical gemcitabine in superficial transitional cell carcinoma of urinary bladder
    Mohanty, N. K.
    Nayak, Rajiba L.
    Vasudeva, Pawan
    Arora, R. P.
    [J]. INDIAN JOURNAL OF UROLOGY, 2008, 24 (01) : 44 - 47
  • [9] A phase II study of gemcitabine and oxaliplatin in advanced transitional cell carcinoma of the bladder
    Zeynep Eroglu
    John P. Fruehauf
    [J]. Cancer Chemotherapy and Pharmacology, 2013, 72 : 263 - 267
  • [10] A phase II study of gemcitabine and oxaliplatin in advanced transitional cell carcinoma of the bladder
    Eroglu, Zeynep
    Fruehauf, John P.
    [J]. CANCER CHEMOTHERAPY AND PHARMACOLOGY, 2013, 72 (01) : 263 - 267
12345